Medigus Net Income from 2010 to 2024

MDGS Stock  USD 2.74  0.10  3.52%   
Medigus Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to about -9.6 M in 2024. From the period from 2010 to 2024, Medigus Net Loss quarterly data regression had r-value of (0.36) and coefficient of variation of (74.63). View All Fundamentals
 
Net Loss  
First Reported
2014-03-31
Previous Quarter
-6.4 M
Current Value
-8.2 M
Quarterly Volatility
3.6 M
 
Yuan Drop
 
Covid
Check Medigus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medigus main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Selling General Administrative of 17.1 M or Selling And Marketing Expenses of 4.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0903, Dividend Yield of 0.52 or Operating Cycle of 119. Medigus financial statements analysis is a perfect complement when working with Medigus Valuation or Volatility modules.
  
This module can also supplement various Medigus Technical models . Check out the analysis of Medigus Correlation against competitors.

Latest Medigus' Net Income Growth Pattern

Below is the plot of the Net Income of Medigus Ltd ADR over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Medigus Ltd ADR financial statement analysis. It represents the amount of money remaining after all of Medigus Ltd ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Medigus' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medigus' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (10.1 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Medigus Net Income Regression Statistics

Arithmetic Mean(6,052,986)
Geometric Mean5,573,911
Coefficient Of Variation(74.63)
Mean Deviation3,564,058
Median(6,598,000)
Standard Deviation4,517,105
Sample Variance20.4T
Range18.2M
R-Value(0.36)
Mean Square Error19.1T
R-Squared0.13
Significance0.18
Slope(366,458)
Total Sum of Squares285.7T

Medigus Net Income History

2024-9.6 M
2023-9.2 M
2022-10.2 M
2021M
2020-6.8 M
2019-14.2 M
2018-6.6 M

Other Fundumenentals of Medigus Ltd ADR

About Medigus Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Medigus income statement, its balance sheet, and the statement of cash flows. Medigus investors use historical funamental indicators, such as Medigus's Net Income, to determine how well the company is positioned to perform in the future. Although Medigus investors may use each financial statement separately, they are all related. The changes in Medigus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medigus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Medigus Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Medigus. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Net Loss-9.1 M-9.5 M
Net Loss-11.7 M-12.3 M
Net Income Applicable To Common Shares7.8 M8.2 M
Net Income Per E B T 1.16  1.10 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medigus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medigus' short interest history, or implied volatility extrapolated from Medigus options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medigus Ltd ADR is a strong investment it is important to analyze Medigus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medigus' future performance. For an informed investment choice regarding Medigus Stock, refer to the following important reports:
Check out the analysis of Medigus Correlation against competitors.
Note that the Medigus Ltd ADR information on this page should be used as a complementary analysis to other Medigus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Medigus Stock analysis

When running Medigus' price analysis, check to measure Medigus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigus is operating at the current time. Most of Medigus' value examination focuses on studying past and present price action to predict the probability of Medigus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigus' price. Additionally, you may evaluate how the addition of Medigus to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is Medigus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medigus. If investors know Medigus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medigus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.70)
Revenue Per Share
67.313
Quarterly Revenue Growth
0.527
Return On Assets
(0.07)
Return On Equity
(0.31)
The market value of Medigus Ltd ADR is measured differently than its book value, which is the value of Medigus that is recorded on the company's balance sheet. Investors also form their own opinion of Medigus' value that differs from its market value or its book value, called intrinsic value, which is Medigus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medigus' market value can be influenced by many factors that don't directly affect Medigus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medigus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medigus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medigus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.